Treatment of Nonmotor Symptoms in Parkinson's Disease.

Int Rev Neurobiol

National Parkinson Foundation International Centre of Excellence, Kings College and Kings College Hospital, London, United Kingdom; Maurice Wohl Clinical Neuroscience Institute, Kings College, London, United Kingdom; National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre (BRC) and Dementia Unit at South London and Maudsley NHS Foundation Trust, London, United Kingdom.

Published: March 2018

Nonmotor symptoms (NMS) are integral to Parkinson's disease (PD) and the management can often be challenging. In spite of the growing evidence that NMS have a key impact on the quality of life of patients and caregivers, most clinical trials still focus on motor symptoms as primary outcomes. As a consequence strong evidence-based treatment recommendations for NMS occurring in PD are spare. In this chapter, the current data addressing the treatment of major NMS such as sleep, cognitive and autonomic dysfunction, and depression and anxiety are described.

Download full-text PDF

Source
http://dx.doi.org/10.1016/bs.irn.2017.03.002DOI Listing

Publication Analysis

Top Keywords

nonmotor symptoms
8
parkinson's disease
8
treatment nonmotor
4
symptoms parkinson's
4
disease nonmotor
4
nms
4
symptoms nms
4
nms integral
4
integral parkinson's
4
disease management
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!